Quantification of Fontan Obstruction as a Marker for Quality of Life and Exercise Performance

Fontan 阻塞的量化作为生活质量和运动表现的标志

基本信息

  • 批准号:
    10514793
  • 负责人:
  • 金额:
    $ 3.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

SUMMARY Single ventricle (SV) malformations are among the most complex congenital heart defects (CHDs), affecting about 2 per 1000 births in the United States. Common palliation for SV patients is the staged Fontan procedure. This procedure culminates in a total cavopulmonary connection (TCPC), designed to connect systemic and pulmonary circulations in series. Immediate post-procedural outcomes are usually favorable. However, various long-term complications afflict the Fontan population, and many are associated with Fontan obstruction. Previous studies define Fontan obstruction as vessel narrowing or elevated energetics in the TCPC; however, they often overlook the performance of the patient’s ventricle, the core issue of SV malformations. Consequently, only weak correlations were observed between formerly defined Fontan obstruction and long-term complications in Fontan patients. Therefore, this proposed work will focus on two prevalent Fontan complications, diminished quality of life (QoL) and reduced exercise performance, to (1) identify an innovative definition of Fontan obstruction that integrates TCPC geometry and/or TCPC hemodynamics with ventricular performance and (2) to quantify the level of newly defined Fontan obstruction for optimal QoL and exercise performance in Fontan patients. Two specific aims will accomplish this project: (1) Quantify Fontan obstruction as a marker of quality of life. The working hypothesis is that an obstruction metric that integrates TCPC geometry and/or TCPC hemodynamics with ventricular performance at rest will provide a better quantification of Fontan obstruction and serve as a marker of QoL. (2) Quantify Fontan obstruction as a marker of exercise performance. This aim hypothesizes that an obstruction metric that integrates TCPC geometry and/or TCPC hemodynamics with ventricular performance (under resting conditions, exercise conditions, and/or the rest-exercise difference) will provide a better quantification of Fontan obstruction and serve as a marker of exercise capacity. Both aims will use cutting-edge, validated computational fluid dynamics and fluid-structure interaction modeling to obtain TCPC hemodynamics and ventricular performance, respectively. The proposed work is of great impact due to its goals of better quantifying Fontan obstruction to improve QoL and exercise performance for Fontan patients. Furthermore, this proposal will enhance undergraduate research and education for the recently established biomedical engineering department at the University of Massachusetts at Lowell. Undergraduate involvement in this project will allow students to experience a broad spectrum of state-of-the-art techniques and acquire skills such as medical image processing and image-based cardiovascular simulations. Additionally, the students will develop a vast network of partnerships among scientists and clinicians from national and international institutions. 1
总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhenglun Alan Wei其他文献

ASSESSING LVOT OBSTRUCTION FOLLOWING TRANSCATHETER MITRAL VALVE REPLACEMENT WITH LAMPOON: NEW INSIGHTS FROM A POST-PROCEDURE ANALYSIS
  • DOI:
    10.1016/s0735-1097(21)02313-5
  • 发表时间:
    2021-05-11
  • 期刊:
  • 影响因子:
  • 作者:
    Keshav Kohli;Zhenglun Alan Wei;Vahid Sadri;Jaffar Khan;John Lisko;Tiffany Netto;Adam Greenbaum;Philipp Blanke;John Oshinski;Robert Lederman;Vasilis Babaliaros;Ajit Yoganathan
  • 通讯作者:
    Ajit Yoganathan
Development of a personalized fluid-structure interaction model for the aorta in human fetuses
  • DOI:
    10.1007/s00366-024-02100-0
  • 发表时间:
    2025-01-07
  • 期刊:
  • 影响因子:
    4.900
  • 作者:
    Zhenglun Alan Wei;Guihong Chen;Biao Si;Liqun Sun;Mike Seed;Shuping Ge
  • 通讯作者:
    Shuping Ge
Fontan Surgical Planning: Previous Accomplishments, Current Challenges, and Future Directions
  • DOI:
    10.1007/s12265-018-9786-0
  • 发表时间:
    2018-01-16
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Phillip M. Trusty;Timothy C. Slesnick;Zhenglun Alan Wei;Jarek Rossignac;Kirk R. Kanter;Mark A. Fogel;Ajit P. Yoganathan
  • 通讯作者:
    Ajit P. Yoganathan
Modeling Transcatheter Mitral Valve Replacement with Anterior Leaflet Laceration using In Vitro and Computational Paradigms
  • DOI:
    10.1080/24748706.2020.1712971
  • 发表时间:
    2020-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Keshav Kohli;Thomas Easley;Zhenglun Alan Wei;Vahid Sadri;John Lisko;Vasilis Babaliaros;John Oshinski;Ajit Yoganathan
  • 通讯作者:
    Ajit Yoganathan
ON THE DYNAMICS OF THE NEO-LVOT FOLLOWING TRANSCATHETER MITRAL VALVE REPLACEMENT WITH ANTERIOR LEAFLET LACERATION
  • DOI:
    10.1016/s0735-1097(20)31945-8
  • 发表时间:
    2020-03-24
  • 期刊:
  • 影响因子:
  • 作者:
    Keshav Kohli;Zhenglun Alan Wei;Vahid Sadri;John Lisko;Jaffar Khan;Robert Lederman;Philipp Blanke;John Oshinski;Vasilis Babaliaros;Ajit Yoganathan
  • 通讯作者:
    Ajit Yoganathan

Zhenglun Alan Wei的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 3.99万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 3.99万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 3.99万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 3.99万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 3.99万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 3.99万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 3.99万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 3.99万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 3.99万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 3.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了